HEALTH CANADA: Stability Testing of New Drug Substances and Products
This guidance document is a revised version of the ICH Q1A(R) guidance document and defines the stability data package for a new drug substance or drug product. This revised Q1A(R2) guidance document was necessary as a result of the adoption of ICH guidance document Q1F – Stability Data Package for Registration Applications in Climatic Zones III and IV. The changes made to the Q1A(R) guidance document are outlined in the accompanying covering note to this guidance document.
Read More